Cargando…
Haemodiafiltration and haemodialysis should be reported separately by kidney replacement therapy registries
Autores principales: | Steinwandel, Ulrich, Davies, Hugh, Gibson, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155220/ https://www.ncbi.nlm.nih.gov/pubmed/35664284 http://dx.doi.org/10.1093/ckj/sfac039 |
Ejemplares similares
-
Haemodiafiltration elicits less platelet activation compared to haemodialysis
por: Becs, Gergely, et al.
Publicado: (2016) -
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
por: Blankestijn, Peter J, et al.
Publicado: (2020) -
Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration
por: Santos, Alba, et al.
Publicado: (2020) -
Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration
por: Voigt, Manuel, et al.
Publicado: (2019) -
Residual Renal Function – How Fast Does the Residual Urine Output Function Decline in the First Year of Haemodialysis? – A Scoping Review
por: Steinwandel, Ulrich, et al.
Publicado: (2022)